SunOpta/$STKL

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About SunOpta

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Ticker

$STKL
Primary listing

Employees

1,248

SunOpta Metrics

BasicAdvanced
$456M
2,018.83
$0.00
1.08
-

What the Analysts think about SunOpta

Analyst ratings (Buy, Hold, Sell) for SunOpta stock.

Bulls say / Bears say

In Q2 FY2025, SunOpta delivered 12.9% year-over-year revenue growth to $191.5 million and swung to $4.4 million in earnings from continuing operations from a prior-year loss, with adjusted EBITDA rising 13.9% to $22.7 million, reaffirming its 2025 guidance. (TipRanks)
SunOpta beat Zacks consensus in Q1 FY2025 with adjusted EPS of $0.04 vs $0.02 estimate and revenues of $201.63 million, marking its third earnings beat in four quarters and underscoring resilient demand for its plant-based products. (Nasdaq)
Management raised its 2025 outlook, revising revenue guidance to $805 million–$815 million and projecting adjusted EBITDA growth of 12%–16%, signaling confidence in sustained margin expansion and operational leverage. (TipRanks)
Q2 FY2025 gross margin was pressured by $1.6 million in tariff-related headwinds, contributing to an 80 bps drag on adjusted gross margin despite higher volumes. (TipRanks)
SunOpta’s net debt of $271 million and net leverage ratio of 2.9x as of Q2 heighten financial risk and interest costs, potentially constraining future investment flexibility. (TipRanks)
STKL shares plunged to a 52-week low of $4.00 amid a 37.8% year-to-date decline, reflecting investor concerns over market headwinds and operational execution risks. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2025.

SunOpta Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SunOpta Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $STKL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs